➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Express Scripts
Merck
AstraZeneca
McKesson

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Patent: 9,994,550

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,994,550
Title:Heterocyclic modulators of lipid synthesis for use against cancer and viral infections
Abstract: Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by dysregulation of a fatty acid synthase pathway by the administration of such compounds.
Inventor(s): Wagman; Allan S. (Belmont, CA), Johnson; Russell J. (Sunnyvale, CA), Zaharia; Cristiana A. (Redwood City, CA), Cai; Haiying (Cupertino, CA), Hu; Lily W. (Palo Alto, CA), Duke; Greg (Menlo Park, CA), Ohol-Gupta; Yamini (Menlo Park, CA), Heuer; Timothy (Menlo Park, CA), O\'Farrell; Marie (Menlo Park, CA)
Assignee: 3-V Biosciences, Inc. (Menlo Park, CA)
Application Number:15/110,154
Patent Claims:see list of patent claims

Details for Patent 9,994,550

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial 3-V Biosciences, Inc. (Menlo Park, CA) 2034-01-07 RX search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25   Start Trial 3-V Biosciences, Inc. (Menlo Park, CA) 2034-01-07 RX Orphan search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26   Start Trial 3-V Biosciences, Inc. (Menlo Park, CA) 2034-01-07 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Dow
Express Scripts
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.